Bristol-Myers Squibb Company P/B Ratio
Data as of June 01, 2026
P/B Ratio
5.82
Stock Price
$57.18
Book Value/Share
$9.83
Sector
Healthcare
How It's Calculated
5.82 = $57.18 ÷ $9.83
What This Means
Bristol-Myers Squibb Company's P/B ratio of 5.82 is above average, reflecting investor confidence in the company's ability to generate returns above its asset base.
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) operates in the Healthcare sector, specifically in Drug Manufacturers - General. With a market capitalization of about $116.77B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $57.18, within a 52-week range of $42.52 to $62.89 (-9.1% from the high, +34.5% from the low). Beta of 0.26 indicates relatively lower volatility versus the market.
Trailing profit margin is about 15.0%, signaling a solid profit margin for its industry.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Bristol-Myers Squibb Company, P/B is especially useful when earnings are volatile or temporarily depressed. In Healthcare, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Healthcare names on our S&P 100 coverage, Bristol-Myers Squibb Company's P/B ratio of 5.82 can be compared with peers such as LLY (31.65), JNJ (6.68), UNH (3.53). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Healthcare stocks.
Key Takeaways
- BMY is grouped in the Healthcare sector for peer comparisons.
- Recent beta of 0.26 suggests lower-than-market price sensitivity.
- Trailing profit margin of 15.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for BMY.
Other BMY Metrics
Frequently Asked Questions
What does BMY's price-to-book ratio indicate?
P/B compares share price to book value per share. Bristol-Myers Squibb Company's P/B of 5.82 reflects how the market prices net assets — especially relevant for asset-heavy Healthcare business models.
Is 5.82 above or below book value?
A P/B above 1.0 (5.82) means the market values BMY above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Healthcare?
Peer P/B levels in Healthcare (e.g. LLY (31.65), AMGN (19.78), GILD (7.10)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →